Published in Am J Physiol Regul Integr Comp Physiol on December 02, 2015
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31
The global burden of injuries. Am J Public Health (2000) 8.32
Acute traumatic coagulopathy. J Trauma (2003) 5.24
Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma (2008) 3.40
Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care (2007) 2.51
Acute coagulopathy of trauma in the rat. Shock (2013) 2.08
The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost (2013) 1.92
Increasing trauma deaths in the United States. Ann Surg (2014) 1.88
Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Crit Care Med (2002) 1.81
New fundamentals in hemostasis. Physiol Rev (2013) 1.70
Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg (2012) 1.63
Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma (2008) 1.58
Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med (2001) 1.53
Platelet activation and function after trauma. J Trauma (2001) 1.30
Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med (2011) 1.16
New anticoagulants. Blood (2004) 1.13
α-2-Macroglobulin: a physiological guardian. J Cell Physiol (2013) 1.13
Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg (2012) 1.05
Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock (2014) 1.00
Tranexamic acid for trauma patients: a critical review of the literature. J Trauma (2011) 1.00
Acute traumatic coagulopathy in severe injury: incidence, risk stratification, and treatment options. Dtsch Arztebl Int (2011) 0.99
Mechanisms of plasmin-catalyzed inactivation of factor VIII: a crucial role for proteolytic cleavage at Arg336 responsible for plasmin-catalyzed factor VIII inactivation. J Biol Chem (2006) 0.97
Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival. J Trauma Acute Care Surg (2012) 0.96
Trauma-associated hyperfibrinolysis. Hamostaseologie (2011) 0.93
Plasmin converts factor X from coagulation zymogen to fibrinolysis cofactor. J Biol Chem (1999) 0.92
Thrombin inhibition by the serpins. J Thromb Haemost (2013) 0.89
Protein C degradation in vitro by neutrophil elastase. Biol Chem Hoppe Seyler (1991) 0.88
Proteolytic processing of human coagulation factor IX by plasmin. Blood (2000) 0.87
Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: A critical appraisal of the medical literature and available alternatives. J Trauma Acute Care Surg (2015) 0.83
Changes in regional vascular resistance and blood volume after hemorrhage in fed and fasted awake rats. J Appl Physiol (1985) (1995) 0.83
Mechanistic determinates of the acute coagulopathy of trauma (ACoT) in patients requiring emergency surgery. Int J Burns Trauma (2012) 0.82
The role of the membrane in the inactivation of factor va by plasmin. Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function. J Biol Chem (2001) 0.82
Role of intestinal fluid in restitution of blood volume and plasma protein after hemorrhage in awake rats. Am J Physiol (1995) 0.82
Platelets modulate the proteolysis of factor VIII:C protein by plasmin. Blood (1986) 0.79
Inactivation of factor Va by plasmin. J Biol Chem (1987) 0.78
The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg. Thromb Res (1983) 0.77
Plasmin and the thrombin-thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi. J Thromb Haemost (2013) 0.77